Reduced TREM2 activation in microglia of patients with Alzheimer's disease-Reference-Cited by-同舟云学术

Reduced TREM2 activation in microglia of patients with Alzheimer's disease

Published:2021-09-28 Issue:11 Volume:11 Page:3063-3080
ISSN:2211-5463
Container-title:FEBS Open Bio
language:en
Short-container-title:FEBS Open Bio

Author:

Okuzono Yuumi¹,Sakuma Hiroyuki²,Miyakawa Shuuichi¹,Ifuku Masataka¹,Lee Jonghun³,Das Debashree⁴,Banerjee Antara⁵,Zhao Yang³,Yamamoto Koji³,Ando Tatsuya³,Sato Shuji²^ORCID

Affiliation:

1. Immune Cell Engineered Therapeutics Research, Takeda Pharmaceutical Company Limited Fujisawa Japan

2. Neuroscience Drug Discovery Unit Research, Takeda Pharmaceutical Company Limited Fujisawa Japan

3. Computational Biology Research, Takeda Pharmaceutical Company Limited Fujisawa Japan

4. Early Target Discovery Research, Takeda California, Inc. San Diego CA USA

5. GI Immunology Research, Takeda California, Inc. San Diego CA USA

Funder

Takeda Pharmaceutical Company

Publisher

Wiley

Subject

General Biochemistry, Genetics and Molecular Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/2211-5463.13300

Reference97 articles.

1. A molecular approach in drug development for Alzheimer’s disease

2. Variant ofTREM2Associated with the Risk of Alzheimer's Disease

3. TREM2 Variants in Alzheimer's Disease

4. Gene Dose of Apolipoprotein E Type 4 Allele and the Risk of Alzheimer's Disease in Late Onset Families

5. Integrated Systems Approach Identifies Genetic Nodes and Networks in Late-Onset Alzheimer’s Disease

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Microglia Gravitate toward Amyloid Plaques Surrounded by Externalized Phosphatidylserine via TREM2;Advanced Science;2024-07-09

2. Neuraminidase 1 regulates the cellular state of microglia by modulating the sialylation of Trem2;2024-05-20

3. Microvascular damage, neuroinflammation and extracellular matrix remodeling in Col18a1 knockout mice as a model for early cerebral small vessel disease;Matrix Biology;2024-04

4. TREM2 in Alzheimer's disease: Structure, function, therapeutic prospects, and activation challenges;Molecular and Cellular Neuroscience;2024-03

5. Targeting CaN/NFAT in Alzheimer’s brain degeneration;Frontiers in Immunology;2023-11-23